Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate ...

Dow drops 400 points as weak consumer sentiment and UnitedHealth slump weigh on US stocks. Inflation fears and PMI data add ...

Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage biopharmaceutical company developing innovative therapeutics for rare diseases that affect bone health and blood ...

In short, that extra spending probably won’t give the European economy the shot in the arm it so dearly needs – or at least ...

Millions of Americans take proton pump inhibitors (PPIs) like Prilosec, Nexium, and Prevacid to manage acid reflux, heartburn, and gastroesophageal reflux disease (GERD).

Apple's iPhone 16e marks a significant shift in its entry-level smartphone lineup, moving away from the "budget" SE branding ...

Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Broadcom Inc. (AVGO), Thermo Fisher ...

Lloyds, led by boss Charlie Nunn (pictured), has earmarked an extra £700m for compensation on top of a previously announced £450m.

Trump's tariffs are used as negotiation tools with uncertain long-term effects on inflation and the US dollar's strength.

Governors and lawmakers in some of the fastest growing states are now pursuing tort reform for the same reason the seek to ...